Almirall, S.A. (FRA:E2Z)

Market Cap	2.72B
Revenue (ttm)	1.09B
Net Income (ttm)	42.05M
Shares Out	n/a
EPS (ttm)	0.20
PE Ratio	64.77
Forward PE	31.42
Dividend	0.15 (1.19%)
Ex-Dividend Date	May 15, 2025

Volume	n/a
Average Volume	3
Open	12.52
Previous Close	12.66
Day's Range	12.52 - 12.52
52-Week Range	8.09 - 12.74
Beta	n/a
RSI	57.04
Earnings Date	Nov 10, 2025

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun...

• Industry: Pharmaceutical Preparations
• Founded: 1943
• Employees: 2,026
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: E2Z